Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced NSCLC patients treated with concurrent chemoradiotherapy

03/06/2019
/ Publications

This study evaluated pre-treatment and post-treatment F-FDG PET/CT of 18 locally advanced NSCLC patients treated with definitive photon or proton RT. In nine...

Hypofractionated PBT for centrally located lung cancer.

03/05/2019
/ Publications
/
Hypofractionation

This study from Japan reported outcomes of 39 patients who received hypofractionated PBT for centrally located cT1-2N0M0. Twenty-four patients (62%) were...

Clinical outcomes after IMPT with concurrent chemotherapy for inoperable NSCLC.

03/04/2019
/ Publications
/
Chemotherapy

Published in the Green Journal, this study by MD Anderson reported disease control, survival, and toxicity in patients with advanced inoperable non-small cell...

PBT outcomes for localized unresectable hepatocellular carcinoma.

03/01/2019
/ Publications
/
Survival
Toxicity

A MD Anderson study published in the Green Journal reported outcomes of forty-six patients with HCC, Child-Pugh class of A or B, no prior radiotherapy treated...

Consensus Report From the Miami Liver PT Conference.

03/05/2019
/ Publications

This paper is based on the Liver Focus Group supported by IBA. An International group of 22 liver cancer experts from 18 institutions were brought together in...

What Conditions Make PBT Financially Viable in Western Canada?

11/11/2018
/ Publications

This is a business case and concluded the potential for a financially viable PBT facility in Western Canada. A single-vault, compact PBT unit operating 10 hours...

Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.

10/10/2020
/ Publications
/
Toxicity
IMPT

This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...

Literature Review of PBT for Prostate Cancer in Japan.

01/01/2019
/ Publications

A literature review on published works related to proton beam therapy for prostate cancer in Japan. 23 articles were analyzed including fourteen observational...

LT results of a phase II study of hypofractionated PT for prostate cancer

01/01/2019
/ Publications

A study by the Korean group of National Cancer Center. Eighty-two patients with T1-3bN0M0 prostate cancer were randomized to one of five arms: Arm 1, 60 cobalt...

Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer

08/08/2018
/ Publications
/
Toxicity

A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...